39 research outputs found
An analysis of discrepancies between United Kingdom cancer research funding and societal burden and a comparison to previous and United States values
Full text link
Cribriform-murular variant of papillary thyroid carcinoma with neuroendocrine differentiation and aggressive behaviour in a patient with familial adenenomatous polyposis coli: a case report.
No full textUK 2022 Consensus on Normal Tissue Dose-Volume Constraints for Oligometastatic, Primary Lung and Hepatocellular Carcinoma Stereotactic Ablative Radiotherapy
No full textThe use of stereotactic ablative radiotherapy (SABR) in the UK has expanded over the past decade, in part as the result of several UK clinical trials and a recent NHS England Commissioning through Evaluation programme. A UK SABR Consortium consensus for normal tissue constraints for SABR was published in 2017, based on the existing literature at the time. The published literature regarding SABR has increased in volume over the past 5 years and multiple UK centres are currently working to develop new SABR services. A review and update of the previous consensus is therefore appropriate and timely. It is hoped that this document will provide a useful resource to facilitate safe and consistent SABR practice
Diagnostic performance of FDG PET/CT to detect subclinical HNSCC recurrence 6聽months after the end of treatment
No full textExtent of surrounding edema does not correlate with acute complications after radiosurgery for melanoma brain metastases
No full text
Stabilization of RNA through Absorption by Functionalized Mesoporous Silicate Nanospheres
No full textLong noncoding RNA LINC00460 aggravates invasion and metastasis by targeting miR-30a-3p/Rap1A in nasopharyngeal carcinoma
No full textEarly stage non-small cell lung cancer treated with pencil beam scanning particle therapy: retrospective analysis of early results on safety and efficacy
No full text
